Discussion over the safety of contraceptive pills has been asked for by the Food and Drug Administration. Contraceptive pills containing drospirenone have attracted controversies as it has been found that the contraceptive pills containing drospirenone can cause blood clots.

With clinical trials of cancer drug Avastin showing that the drug apparently does little to help enhance the life-span of breast cancer patients or to effectively control their tumors, the US Food and Drug Administration (FDA) Friday withdrew the approval of the drug as a treatment for those patients whose breast cancer has spread to other organs.

Addressing the Senate Health, Education, Labor and Pensions Committee on Thursday Food and Drug Administration (FDA) Commissioner Margaret Hamburg vehemently endorsed the legislation that would bring about a comprehensive overhaul in the agency's functioning, thereby giving it new tools to perk up food safety.

According to Associated Press reports, in his weekly radio address Saturday, President Obama put forth his picks for the posts of FDA Commissioner and Deputy Commissioner. As expected, he named Margaret Hamburg – the New York City Health Commissioner - for the top FDA post; and Joshua Sharfstein - Baltimore Health Commissioner - as her principal deputy.

President Barack Obama is likely to hand over that reins of the distraught FDA - Food and Drug Administration - to Margaret A. Hamburg, an ex-Health Commissioner, New York City. Obama's pick for the FDA's Deputy Commissioner is Joshua Sharfstein, the Baltimore Health Commissioner.